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Can anti-erosion dentifrices also
provide effective plaque control?
Abstract: Objective: While gingivitis and caries continue to be
prevalent issues, there is growing concern about dental erosion
induced by dietary acids. An oral hygiene product that protects
against all these conditions would be beneﬁcial. This study
investigated the potential of two anti-erosion dentifrices to inhibit
plaque. Methods: This was a randomized, three-period, two-treatment,
double-blind, crossover study evaluating a stannous chloride⁄sodium
ﬂuoride dentifrice (SnCl2⁄NaF, blend-a-med
  Pro Expert) and a
popular anti-erosion dentifrice (NaF, Sensodyne
  ProNamel
TM). During
Period 3, subjects were randomized to repeat one treatment to
evaluate any product carryover effects. Each treatment period was
17 days. Test dentifrices were used with a standard manual
toothbrush. Digital plaque image analysis (DPIA) was employed
at the end of each period to evaluate plaque levels (i) overnight
(AM prebrush); (ii) post-brushing with the test product (AM post-brush);
and (iii) mid-afternoon (PM). Analysis was conducted via an objective
computer algorithm, which calculated total area of visible plaque.
Results: Twenty-seven subjects completed the study. At all time
points, subjects had statistically signiﬁcantly (P £ 0.0001) lower plaque
levels after using the SnCl2⁄NaF dentifrice than the NaF dentifrice. The
antiplaque beneﬁt for the SnCl2⁄NaF dentifrice versus the NaF
dentifrice was: AM prebrush = 26.0%; AM post-brushing = 27.9%;
PM = 25.7%. Conclusions: The SnCl2⁄NaF dentifrice provided
signiﬁcantly greater daytime and overnight plaque inhibition than the
NaF toothpaste. When recommending dentifrice to patients
susceptible to dental erosion, clinicians can consider one that also
inhibits plaque.
Key words: clinical trial; dental hygiene; dentifrice⁄gel; ﬂuoride; oral
hygiene; plaque control; plaque formation
Introduction
Dental erosion is deﬁned as the loss of tooth substance by acid exposure
not involving bacteria (1). The oral health problem of dietary induced
dental erosion is not a new one. There have been reports in the literature
for decades documenting the problems associated with erosion of the
hard tissues due to dietary acids (2, 3). However, more recently, epidemi-
ological studies and case reports have indicated that dental erosion is a
growing problem, particularly in the last 10–20 years (4, 5). Periodontal
diseases and caries continue to be prevalent issues in oral medicine. But
indeed, with caries amongst children in developed countries at historically
low levels (6), erosion is now becoming a focus of dental research because
it has the potential to cause signiﬁcant dental health problems as the cur-
rent child population ages (4).
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turers of oral care products have begun to market daily use
products with claimed erosion protection beneﬁts. There are a
number of technological routes available, providing varying
levels of protection against dietary acids, which can cause den-
tal erosion. One popular approach is the use of a common car-
ies-preventive ﬂuoride as a protective system against dietary
erosion. Such ﬂuoride sources, like sodium ﬂuoride (NaF),
have been reported to provide some level of protection against
erosive loss of hard tissue (7, 8). Conversely, there are also
reports of research where ﬂuoride has provided no, or very lim-
ited, protective beneﬁt (9, 10). Recent increases in observed
levels of erosion (4) suggest that the efﬁcacy of regular ﬂuoride
toothpastes alone as preventive measure against dental erosion
is not sufﬁcient.
A second common route to erosion prevention found within
the literature is the use of stannous compounds and in particu-
lar stannous ﬂuoride (SnF2) (11, 12). The mode of action for
SnF2 is still not completely understood and continues to be an
area of current research (13). The formation on the hard tissue
of a micro-thin tin ﬂuorophosphate layer has been suggested
(14), while other research suggests incorporation of stan-
nous⁄tin into the ﬁrst few microns of enamel is essential for
anti-erosion efﬁcacy (13). This has led to discussion of the rel-
ative roles of stannous ions (Sn
2+) and ﬂuoride ions (F
)) (12)
with recently reported in vitro work (15) indicating that in iso-
lation each is only moderately effective, but when in combina-
tion, they are highly effective.
While daily use products to help prevent dental erosion is
clearly a growing need, other oral health issues remain a signi-
ﬁcant problem. Poor gingival health has not surprisingly been
reported by periodontal specialists to negatively impact the
quality of life of patients (16). There remains a considerable
need for daily use products, which will help prevent plaque-
associated conditions such as gingivitis and dental caries. Effec-
tive plaque control is the aspect of oral care which is mostly
under the control of the patient, and includes use of mechanical
hygiene tools to remove plaque and effective chemotherapeutic
products, which help inhibit plaque regrowth (17).
The need to address multiple oral health conditions can
present a challenge for the clinician when advising patients on
home care choices. Many patients who need protection from
dietary erosion also need help with plaque control. Products
that are effective at helping to prevent both erosion and
plaque-related conditions are a preferable solution. The
research presented in this article was undertaken to evaluate
the plaque inhibition properties of two dentifrices, which
employ distinct technological routes to the provision of erosion
protection. An established dentifrice (Sensodyne
  ProNa-
mel
TM; GlaxoSmithKline, Istanbul, Turkey) marketed under a
claim to help prevent dental erosion was tested against a
newly introduced dentifrice (blend-a-med* Pro Expert denti-
frice; Procter & Gamble, Gross Gerau, Germany), also claim-
ing an erosion-preventive beneﬁt, for their ability to inhibit
plaque formation in vivo.
Materials and methods
This study used a two-treatment, three-period, randomized,
double-blind, crossover design, which has been published pre-
viously (18, 19). In this design, the third period is a repeat of
the treatment used in the second period, a strategy employed
to control for potential carryover effects and improve statistical
power. Each treatment period was for 17 days, with a 4-day
washout between periods. Plaque evaluations were conducted
on days 15, 16 and 17 of each treatment period early in the
morning, before toothbrushing (‘am prebrushing’). In addition,
on the same days, plaque evaluations were conducted immedi-
ately after early morning toothbrushing for 40 s (‘am post-
brushing’) and mid-afternoon (pm). All plaque evaluations were
performed using a standardized digital plaque image analysis
(DPIA) method (20) (Fig. 1).
Treatments
1 1450 ppm NaF formulation with SnCl2 as key excipient.
(blend-a-med* Pro Expert dentifrice; Procter & Gamble),
referred to as SnCl2⁄NaF.
2 A 1450 ppm NaF dentifrice with potassium nitrate widely
marketed across Europe (Sensodyne
  ProNamel
TM; Glaxo-
SmithKline), referred to as NaF.
Study design
After recruitment, all subjects underwent an oral soft tissue
examination, provided a medical history and were checked
against inclusion⁄exclusion criteria. To be eligible, subjects
needed to be in good oral and general health, not have a sensi-
tivity⁄allergy to dyes (especially ﬂuorescein) and agree to
refrain from use of non-study oral health products for the dura-
tion of the trial. Subjects were excluded if they were using
medication (e.g. antibiotics), were pregnant or nursing, were in
poor dental health, or had a dental appliance, which would
interfere with the DPIA procedure. They were also excluded
if they had any dental treatments (including a dental prophy-
laxis) carried out within 2 weeks of the start of the trial. Before
the study commenced, all subjects signed the study informed
consent. The application of the DPIA methodology for denti-
frice research had been previously reviewed and approved by
the Institutional Ethics Review Committee.
Prior to the treatment phase of the study, subjects used a
standard ﬂuoride toothpaste and manual toothbrush (Crest
 
Decay Prevention 1450 ppm NaF and Oral-B
  P35 Indicator
manual toothbrush; Procter & Gamble, Gross Gerau, Germany)
twice per day for at least 7 days, to wash out any treatment
effects from products used in their normal oral hygiene regi-
men. This standard product combination was also used during
the 4-day washout between treatment periods. A balanced
treatment assignment was achieved by randomizing subjects to
*Also branded Oral-B
 , Crest
  and Ipana
 , depending on the local
country brand name.
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within each strata based on high, medium, or low pre-acclima-
tion plaque scores, ensuring that each sequence group had a
range of plaque growth rates. This was performed using
recently collected data during a period when each subject was
using the standard product combination.
On Monday morning of the ﬁrst period, subjects were
provided with a randomly assigned treatment toothbrush⁄
toothpaste in blinded packaging (white tubes) and usage
instructions. Subjects were instructed to brush twice per day
as they normally would. On the Monday, Tuesday and
Wednesday evenings of each week during a treatment period,
subjects only brushed their lingual surfaces, while ensuring the
toothpaste slurry was swished around the whole oral cavity.
This previously reported design enables the chemical inhibi-
tion effects of antimicrobial pastes to be clearly demonstrated
on facial surfaces (i.e. the imaged surfaces when DPIA is used)
separate from the plaque effects of toothbrushing. This brush-
ing procedure maintains a largely representative delivery of
the toothpaste.
27 subjects recruited and given OST examination
Population randomised into two groups based on screening plaque level
Group 1 Group 2
Mon AM: provided with product A
Acclimatise on standard sodium fluoride brush & manual paste for at least 7 days
Mon AM: provided with product B
17 days consecutive use with standard manual toothbrush
Plaque evaluations on mornings and afternoons of day 15, 16 & 17
Both groups switch to washout product for 4 days
OST examination and study 
exit
Plaque level screening conducted (for group balancing)
Mon AM: provided with product B Mon AM: provided with product A
17 days consecutive use with standard manual toothbrush
Plaque evaluations on mornings and afternoons of day 15, 16 & 17
Both groups switch to washout product for 4 days
Mon AM: provided with product B (repeat) Mon AM: provided with product A (repeat)
17 days consecutive use with standard manual toothbrush
Plaque evaluations on mornings and afternoons of day 15, 16 & 17
Fig. 1. Study design.
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Anterior facial plaque coverage was measured using DPIA.
The use of DPIA for comparative product performance for
plaque inhibition via hard tissue plaque coverage measure-
ment has been reported in the literature on a number of
occasions (21, 22). The imaging system used has been previ-
ously fully described by Sagel and Gerlach (23) with the
reapplication for plaque analysis subsequently described by
Bellamy and colleagues (20).
All subjects had am prebrushing plaque evaluated between
7:30 am and 9:30 am on evaluation days (at least 8 h after
brushing the previous evening). On these mornings, subjects
were required not to brush their teeth, eat, drink (except
water) or smoke prior to evaluation. Five millilitres of a
1240 ppm solution of ﬂuorescein (pH 6.0) was used to disclose
the plaque. After a 1-min rinse with the ﬂuorescein, three
phosphate buffer rinses (pH 6.0) were used to stabilize mouth
pH and wash away unattached dye after which immediate
DPIA imaging of the facial surfaces of the front 12 teeth
(canine to canine, maxillary and mandibular) was conducted.
Subjects then brushed for 40 s with the test product and a
post-brushing image was taken following the same disclosing
and imaging procedure. Prior to the pm measure, which was
taken 5–6 h after the morning brushing, subjects were required
to refrain from eating and drinking for 30 min before their
imaging appointment, to avoid food debris being present in
the oral cavity. The same procedures were followed as with
the previous two plaque assessments.
An image analysis algorithm was used to classify pixels (22)
in a deﬁned region of interest (the 12 teeth facial anterior sur-
faces) into one of four categories: teeth, gums, plaque or back-
ground. The percentage of the anterior facial surfaces covered
with plaque was then calculated using the equation:
% Plaque coverage = [plaque pixels / (tooth pixels
+ plaque pixels)] * 100
All the computer analysis output was checked by an expert
in image analysis blinded to treatment for consistency and
accuracy. Images that were not well classiﬁed, or of poor qual-
ity, were excluded from study results.
Statistical methods
Percentage plaque area coverage measurements from each of
3 days were averaged separately for each subject, period and
time point (am prebrush, am post-brush and pm). For each time
point, analysis of variance for the crossover design (general lin-
ear mixed model) was used to compare the per cent plaque
area coverage between treatments using period and treatment
dentifrice as ﬁxed effects and subject as a random effect. The
carryover effect was tested for each time point, was not statisti-
cally signiﬁcant (P > 0.31) and was subsequently removed
from each statistical model. All statistical comparisons were
two-sided using a 0.05 signiﬁcance level.
Results
Twenty-eight subjects were enrolled in the study; one subject
was not eligible and was dropped from the study due to atypi-
cal tooth characteristics. Twenty-seven subjects were eligible
for the research and completed the study, providing evaluable
data at all plaque measurement periods with one exception
(one subject missed Period 3). No adverse events were
recorded by the investigator and no product use discomfort
was reported by the subjects. All images were considered to be
of sufﬁcient quality to be included in the analysis, and no
images needed to be excluded during analysis due to poor
classiﬁcation by the computer algorithm. Subjects ranged in
age from 25 to 55 years with a mean of 34.5 years and 15 sub-
jects were women (55.5%).
Plaque area coverage at the end of the treatment period
when subjects had been using the SnCl2⁄NaF dentifrice was
signiﬁcantly lower (P < 0.0001) than when subjects had been
using the NaF dentifrice. This was true for all the three time
points: am prebrushing, am post-brushing and pm. Table 1
shows the mean plaque coverage at each time point and the
comparative difference in plaque between the products.
Overnight plaque growth (i.e. am prebrushing) when subjects
were using the SnCl2⁄NaF dentifrice was on average 26.0%
less than when subjects were using the NaF dentifrice
(P < 0.0001). A 40-s toothbrushing with either treatment
reduced plaque coverage by a similar proportion (59.9% for the
SnCl2⁄NaF dentifrice and 58.8% for the NaF dentifrice). How-
ever, this meant when subjects were using the SnCl2⁄NaF
treatment, plaque coverage immediately after brushing was
signiﬁcantly lower than when subjects were using the NaF
treatment (27.9% less plaque with SnCl2⁄NaF, P = 0.0001) as
they had less plaque regrowth prior to brushing.
After a period of daytime plaque regrowth, subjects who had
used the SnCl2⁄NaF dentifrice early in the morning had
25.7% less plaque coverage than subjects who were using the
NaF dentifrice (P < 0.0001).
Discussion
This study found that two distinctly different sodium ﬂuoride
dentifrice products developed to protect against dietary erosion
differed in their ability to prevent plaque formation. The
Table 1. Treatment comparisons for plaque area coverage (%)
Timepoint⁄
Treatment Mean (SE)
% Reduction
versus NaF
Two-sided
P-value
AM prebrush
NaF 15.52 (1.10) 26.0 <0.0001
SnCl2⁄NaF 11.49 (1.11)
AM post-brush
NaF 6.39 (0.81) 27.9 0.0001
SnCl2⁄NaF 4.61 (0.81)
PM
NaF 11.92 (1.08) 25.7 <0.0001
SnCl2⁄NaF 8.86 (1.08)
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compared with the NaF dentifrice overnight (at least 8 h) and
throughout the day (5–6 h). These differences were highly sig-
niﬁcant (P-values <0.0001). In addition, immediately after
tooth brushing, subjects’ plaque coverage was 27.9% lower
when they brushed with SnCl2⁄NaF compared with the NaF
treatment.
The plaque inhibition beneﬁt of the SnCl2⁄NaF toothpaste
is attributed to the bioavailability of stannous ions in the pres-
ence of ﬂuoride ions (24). Stannous ﬂuoride has been shown to
be an effective antiplaque agent in numerous published
reports (20–22, 25, 26). A recent study using a virtually identi-
cal design compared a 0.454% stannous ﬂuoride dentifrice with
sodium hexametaphosphate as a key excipient (SnF2) to the
same NaF dentifrice tested here (19). When subjects used the
SnF2 dentifrice, 23.0% less plaque coverage was measured
after overnight regrowth, and 22.6% less plaque coverage dur-
ing the daytime compared with the NaF dentifrice, results
notably similar to those reported in this study. Comparison of
the SnCl2⁄NaF data reported in this article with other studies
suggests plaque inhibition efﬁcacy from the SnCl2⁄NaF denti-
frice to be in the same range as this extensively tested stan-
nous ﬂuoride⁄sodium hexametaphosphate positive control (21,
22). Moreover, results for the NaF dentifrice in this trial are
consistent with limited reports in the literature, which do not
demonstrate efﬁcacy for this active combination as a plaque
control agent (19). Bellamy and colleagues previously reported
it to be signiﬁcantly inferior to a positive control dentifrice for
overnight and daytime plaque inhibition (19).
While both dentifrices are marketed for their anti-erosion
properties, the additional antiplaque properties demonstrated by
the SnCl2⁄NaF dentifrice should be considered by dental
professionals when developing home care treatment plans.
Many patients at risk of dietary dental erosion also struggle with
achieving optimal plaque control. It would be most efﬁcient to
address both conditions with a product that is part of a typical
daily dental care routine. The twice-daily habit of toothbrushing
with the SnCl2⁄NaF dentifrice presents such an opportunity
Conclusion
Clinicians seeking to recommend a daily use dentifrice for
patients susceptible to dental erosion do not need to compro-
mise on antiplaque performance. This study showed the
SnCl2⁄NaF dentifrice to be signiﬁcantly more effective than a
NaF toothpaste at inhibiting plaque growth both overnight
and during the day in a randomized, double-blind, crossover
clinical study.
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